Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

infections other than COVID-19 meta-analysis

INSIGHT FLU-IVIG (Davey)
  NCT02287467		 RCTconvalescent plasma treatmentplaceboinfections other than COVID-19some concern
-/- inconclusive
    IRC005 Study Team
          NCT02572817    		 RCTconvalescent plasma treatmentplaceboinfections other than COVID-19low
    		92/48 inconclusive
      IRC002 Study Team
              NCT01052480      		 RCTconvalescent plasma treatmentcontrolinfections other than COVID-19some concern
      		42/45 inconclusive
        Hung
                  NCT01617317        		 RCTconvalescent plasma treatmentplaceboinfections other than COVID-19some concern
        		17/18 inconclusive

          PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
          Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

           

          - About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons